Generic Pharmaceuticals Company Investment Opportunity in Colombo, Sri Lanka

- The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin.

- The company can sell also in the private market which has a 40% profit margin.

- Own 9.25-acre land valued at USD 1mln approx.

- The license is issued and a government buyback agreement is signed.

- The project is in plug and play stage where the investor can mobilize immediately.

- Commercial manufacturing can commence in 8 months.

Looking to manufacture and supply tablets (paracetamol, Metformin, Atorvastatin, Losartan, Calcium Lactate, Anti retroviral & Anti Malarial, Chlorpheniramine Maleate tablet, Diclofenac tablet, Pantoprazole, Celecoxib capsules, Etoricoxib tablets, Theophylline extended-release, tablet, Fluconazole. ) to the government of Sri Lanka.

Tangible assets include 9.25 acres of land area.

The land area of 9.5 acres is located in the north of the city.

- Company has only one director on the board holding 90% shares, the rest of 10% is owned by the government of Sri Lanka through State Pharmaceutical Corporation.